Table 4. Prevalence Ratio for EBV Latent Antigen CD8+ T-cell IFN-γ Response.
| Kisumu | Nandi | |||
| Constant Pf-malaria infection versus no infection | Constant Pf-malaria infection versus no infection | |||
| PR | 95% CI | PR | 95% CI | |
| Unadjusted | 1.60 | 0.37–6.92 | 1.54 | 0.71–3.35 |
| Age groupsa | ||||
| 0–4 years | 2.10 | 0.22–19.65 | 0.51 | 0.08–3.37 |
| 5–9 years | 1.14 | 0.26–4.99 | 1.47 | 0.58–3.63 |
| ≥10 years | 2.68 | 0.38–18.73 | 1.82 | 0.83–3.99 |
Pf-malaria, Plasmodium falciparum malaria; EBV, Epstein - Barr virus; PR, prevalence ratio; CI, confidence interval.
a
Adjusted for sex and survey period. Unstratified estimates for constant Pf-malaria infections compared to never infected in Kisumu (P = 0.32) and Nandi (P = 0.13) were not significant. Specific details on the number and prevalence of positive responses for each age group are included in Table 2.